SURG · SurgePays, Inc.

Purchased pursuant to limit order for 40,250 shares at $0.5255 entered June 3, 2026. The Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in column 5 does not include other shares of common stock deemed to be beneficially owned by Mr. May (41,750 shares held in the name of XIV LLC, 15,000 shares issuable pursuant to previous restricted share awards, or 12,295 shares held in the name Mr. May's spouse).

Purchased pursuant to limit order for 40,250 shares at $0.5255 entered June 3, 2026. The Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in column 5 does not include other shares of common stock deemed to be beneficially owned by Mr. May (41,750 shares held in the name of XIV LLC, 15,000 shares issuable pursuant to previous restricted share awards, or 12,295 shares held in the name Mr. May's spouse).

Purchased pursuant to limit order for 40,250 shares at $0.5255 entered June 3, 2026. The Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in column 5 does not include other shares of common stock deemed to be beneficially owned by Mr. May (41,750 shares held in the name of XIV LLC, 15,000 shares issuable pursuant to previous restricted share awards, or 12,295 shares held in the name Mr. May's spouse).

On June 1, 2026, the issuer awarded Mr. Cox 500,000 shares pursuant to Mr. Cox's employment agreement with the issuer, as amended, and the issuer's 2022 Omnibus Securities and Incentive Plan. Following the award, Mr. Cox directly held 1,800,000 shares of common stock, and Mr. Cox is also deemed to beneficially own the following shares: (i) 270,745 shares of common stock held in the name of the LC Marital Trust Dated May 17, 2021, (ii) 4,569,384 shares held in the name of BLC Family Investments LLC, and (iii) 561,758 shares held in the name of SMDMM Funding LLC.

On April 1, 2026, the issuer awarded Mr. Cox 500,000 shares pursuant to Mr. Cox's employment agreement with the issuer, as amended, and the issuer's 2022 Omnibus Securities and Incentive Plan. Following the award, Mr. Cox directly held 1,300,000 shares of common stock, and Mr. Cox is also deemed to beneficially own the following shares: (i) 270,745 shares of common stock held in the name of the LC Marital Trust Dated May 17, 2021, (ii) 4,569,384 shares held in the name of BLC Family Investments LLC, and (iii) 561,758 shares held in the name of SMDMM Funding LLC.

On March 24, 2026, Mr. Cox transferred 270,745 to a family trust, the LC Marital Trust Dated May 17, 2021, for no consideration.

On March 24, 2026, Mr. Cox transferred 270,745 to a family trust, the LC Marital Trust Dated May 17, 2021, for no consideration.

On March 23, 2026, Mr. Cox elected to convert $1,000,000 owed to him by the issuer under the consolidated promissory note issued by the issuer to Mr. Cox on or about March 12, 2024, into shares of issuer common stock at $1.25/share (into 800,000 shares of common stock). Those shares were awarded to Mr. Cox on or about March 23, 2026, pursuant to the issuer's 2022 Omnibus Securities and Incentive Plan.

Represents a restricted stock award vesting as to 200,000 RSAs on December 31, 2025.

The beneficial owner effected four separate block purchases on December 10, 2025. The transactions are reported according to the different share prices.

Three of the four purchases, totaling an aggregate of 28,422 shares (25,256 shares, 3,161 shares, and 5 shares), are reported as a single transaction. Each of the separate transactions will be provided at the request of the SEC.

Based upon shares sold at a high price of $2.84, a low price of $2.77, and an average of $2.814. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

These shares were issued pursuant to the provisions of the SurgePays, Inc. 2022 Omnibus Securities and Incentive Plan (the "2022 Plan") and a Restricted Share Award Agreement, dated May 22, 2025, by and between SurgePays, Inc. (the "Company") and Mr. Schurfeld (the "RSA Agreement"). The RSA Agreement provides that the shares will not vest until the earliest to occur of (a) the director no longer serves as a director of the Company for any reason (including, but not limited to, upon death or disability that renders the director incapable of providing services to the Company) other than a Termination of Service for Cause (as defined in the RSA Agreement); (b) upon the occurrence of a Change in Control (as defined in the 2022 Plan); or (c) August 8, 2028.

These shares were issued pursuant to the provisions of the SurgePays, Inc. 2022 Omnibus Securities and Incentive Plan (the "2022 Plan") and a Restricted Share Award Agreement, dated May 22, 2025, by and between SurgePays, Inc. (the "Company") and Ms. Weisberg (the "RSA Agreement"). The RSA Agreement provides that the shares will not vest until the earliest to occur of (a) the director no longer serves as a director of the Company for any reason (including, but not limited to, upon death or disability that renders the director incapable of providing services to the Company) other than a Termination of Service for Cause (as defined in the RSA Agreement); (b) upon the occurrence of a Change in Control (as defined in the 2022 Plan); or (c) August 8, 2028.

These shares were issued pursuant to the provisions of the SurgePays, Inc. 2022 Omnibus Securities and Incentive Plan (the "2022 Plan") and a Restricted Share Award Agreement, dated May 22, 2025, by and between SurgePays, Inc. (the "Company") and Mr. Keys (the "RSA Agreement"). The RSA Agreement provides that the shares will not vest until the earliest to occur of (a) the director no longer serves as a director of the Company for any reason (including, but not limited to, upon death or disability that renders the director incapable of providing services to the Company) other than a Termination of Service for Cause (as defined in the RSA Agreement); (b) upon the occurrence of a Change in Control (as defined in the 2022 Plan); or (c) August 8, 2028.

Includes (i) 1,666 shares held in an IRA owned by Mr. Keys' wife, however, Mr. Keys shares investing and dipositive power over these holdings, (ii) 5,377 shares in total held by two different IRAs owned by Mr. Keys; and (iii) 10,000 shares are held by PCC Holdings LLC. Mr. Keys shares investing and dipositive power over these holdings.

Based upon shares purchased at an average price of $2.75 per share, with a low price of $2.75 per share and a high price of $2.76 per share.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon shares sold at a high price of $1.88, a low price of $1.77, and an average of $1.8216. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon a per share purchase price of $1.6929.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon shares sold at a high price of $1.63, a low price of $1.57, and an average of $1.5947. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon shares sold at a high price of $1.85, a low price of $1.62, and an average of $1.7516. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon shares sold at a high price of $1.75, a low price of $1.61, and an average of $1.67. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

Consists of an RSA grant in the amount of 83,333 set to vest on December 1, 2024.

Includes (i) 83,334 RSAs that vested on July 1, 2024, (ii) 83,334 RSAs that vested on August 1, 2024, (iii) 83,333 RSAs vested on September 1, 2024, (iv) 83,333 RSAs vested on October 1, 2024, and (v) 83,333 RSAs vesting on November 1, 2024.

Represents a restricted stock award vesting as to 66,667 RSAs on December 1, 2024.

Includes restricted stock awards in the amount of (i) 66,667 vested on July 1, 2024, (ii) 66,667 vested on August 1, 2024, (iii) 66,667 vested on September 1, 2024, (iv) 66,667 vested on October 1, 2024, and (v) 66,667 vesting on November 1, 2024.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon shares sold at a high price of $1.62, a low price of $1.50, and an average of $1.5376. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon shares sold at a high price of $1.55, a low price of $1.43, and an average of $1.4782. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

Represents a restricted stock award vesting as to 66,667 RSAs on November 1, 2024.

Includes restricted stock awards in the amount of (i) 66,667 vested on July 1, 2024, (ii) 66,667 vested on August 1, 2024, (iii) 66,667 vested on September 1, 2024, and (iv) 66,667 vesting on October 1, 2024.

Consists of an RSA grant in the amount of 83,333 set to vest on November 1, 2024.

Includes (i) 83,334 RSAs that vested on July 1, 2024, (ii) 83,334 RSAs that are set to vested on August 1, 2024, (iii) RSAs vested on September 1, 2024, and (iv) RSAs vesting on October 1, 2024.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon shares sold at a high price of $2.71, a low price of $2.55, and an average of $2.599. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon shares sold at a high price of $2.91, a low price of $2.75, and an average of $2.781. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

Represents a restricted stock award vesting as to 66,667 RSAs on October 1, 2024.

Includes restricted stock awards in the amount of (i) 66,667 vested on July 1, 2024, (ii) 66,667 vested on August 1, 2024, and (iii) 66,667 vesting on September 1, 2024.

Consists of an RSA grant in the amount of 83,333 set to vest on October 1, 2024.

Includes (i) 83,334 RSAs that vested on July 1, 2024, (ii) 83,334 RSAs that are set to vested on August 1, 2024, and (iii) RSAs vesting on September 1, 2024.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon shares sold at a high price of $3.08, a low price of $2.96, and an average of $3.0088. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

The purpose of the sale is solely to cover taxes with vesting of restricted share awards.

Based upon shares sold at a high price of $3.11, a low price of $3.00, and an average of $3.0517. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

Consists of an RSA grant in the amount of 83,333 set to vest on September 1, 2024.

Includes (i) 83,334 RSAs that vested on July 1, 2024, and (ii) 83,334 RSAs that are set to vest on each of August 1, and September 1, 2024.